<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347933">
  <stage>Registered</stage>
  <submitdate>10/01/2012</submitdate>
  <approvaldate>10/01/2012</approvaldate>
  <actrnumber>ACTRN12612000048886</actrnumber>
  <trial_identification>
    <studytitle>Sarcopenia (loss of muscle mass and function) and physical performance as predictors of clinical outcome in patients on dialysis</studytitle>
    <scientifictitle>A prospective longitudinal study investigating the effect of sarcopenia and physical performance on 9, 12 and 18 month morbidity and mortality in dialysis patients aged over 60 years.</scientifictitle>
    <utrn>U1111-1127-0079</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Sarcopenia / sarcopaenia</healthcondition>
    <healthcondition>Chronic kidney disease</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Kidney disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Measurement of: - biochemical parameters by serum assay of albumin, haematocrit, urea, cholesterol, CRP, transferrin, TNF-alpha - muscle mass using a Fresenius bioimpedance spectrometer - muscle strength using Jamar hand dynamometer for grip strength and isometric muscle strength dynamometer for leg extension - functional muscle capacity using repeated chair stands, timed up-and-go, and 6 minute walk test - subjective nutritional status assessment using the validated "Subjective Global Analysis" questionnaire. 
Testing is performed during a single 45 minute assessment session at baseline, biochemical results are accessed from medical records, and TNF-alpha will be assayed from serum samples.</interventions>
    <comparator>Comparison of mortality rates in moderately and severely sarcopenic patients vs non-sarcopenic patients.</comparator>
    <control>Active</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Morbidity and all cause mortality as assessed by data linkage to medical records</outcome>
      <timepoint>9, 12 and 18 months after baseline data collection</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Morbidity and all cause mortality as assessed by data linkage to medical records</outcome>
      <timepoint>3 months after baseline clinical data collection</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Morbidity and all cause mortality as assessed by data linkage to medical records</outcome>
      <timepoint>6 months after baseline clinical data collection</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Dialysis patients</inclusivecriteria>
    <inclusiveminage>60</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Cardiac pacemaker or implanted defibrillator
Limb amputation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>21/12/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>75</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2145</postcode>
    <postcode>2148</postcode>
    <postcode>2750</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Associate Professor Grahame Elder</primarysponsorname>
    <primarysponsoraddress>Department of Renal Medicine, Westmead Hospital 
PO Box 533, Wentworthville, NSW, 2145</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Westmead Hospital</fundingname>
      <fundingaddress>PO Box 533, Wentworthville, NSW, 2145</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Avalon Moonen</sponsorname>
      <sponsoraddress>203/209 Albion St, Surry Hills, New South Wales

Univeristy of Notre Dame School of Medicine Sydney
16 Oxford St Darlinghurst, NSW, 2010</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Sjorjiana Green</othercollaboratorname>
      <othercollaboratoraddress>University of Notre Dame School of Medicine Sydney
16 Oxford St Darlinghurst, NSW 2010</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A research study into how muscle bulk, strength and physical performance predict clinical outcomes in patients on dialysis.
If the hypothesis proves to be correct, then these simple tests could be used when people are on dialysis or considering commencing dialysis. The results could highlight patients at increased risk of suffering medical complications during dialysis treatments.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney West Area Health Service Human Research Ethics Committee</ethicname>
      <ethicaddress>Westmead Hospital
PO Box 533, Wentworthville, NSW, 2145</ethicaddress>
      <ethicapprovaldate>17/11/2011</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Avalon Moonen</name>
      <address>203/209 Albion St, Surry Hills, NSW, 2010</address>
      <phone>+61 (0)439997819</phone>
      <fax />
      <email>avalon.m@hotmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Associate Professor Grahame Elder</name>
      <address>Department of Renal Medicine, Westmead Hospital
PO Box 533, Wentworthville, NSW, 2145</address>
      <phone>+612 98456962</phone>
      <fax />
      <email>g.elder@garvan.unsw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Avalon Moonen</name>
      <address />
      <phone />
      <fax />
      <email />
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>